|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$1.42 |
$1.42 |
$1.22 |
$1.28 |
1.31M | 04/19/2024 |
$1.26 |
$1.30 |
$1.13 |
$1.17 |
1.44M | 04/22/2024 |
$1.17 |
$1.20 |
$1.12 |
$1.13 |
791.00K | 04/23/2024 |
$1.12 |
$1.17 |
$1.08 |
$1.09 |
1.59M | 04/24/2024 |
$1.10 |
$1.15 |
$1.05 |
$1.09 |
1.20M |
|
Karyopharm Therapeutics is a pharmaceutical company focused on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Co.'s main asset, XPOVIO® (selinexor), a Selective Inhibitors of Nuclear Export compound, is indicated for use in adult patients with multiple myeloma who have received at least one prior therapy; adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. | |
|
Karyopharm Therapeutics (KPTI) has the following price history information. Looking back at KPTI historical stock prices for the last five trading days, on April 18, 2024, KPTI opened at $1.42, traded as high as $1.42 and as low as $1.22, and closed at $1.28. Trading volume was a total of 1.31M shares. On April 19, 2024, KPTI opened at $1.26, traded as high as $1.30 and as low as $1.13, and closed at $1.17. Trading volume was a total of 1.44M shares. On April 22, 2024, KPTI opened at $1.17, traded as high as $1.20 and as low as $1.12, and closed at $1.13. Trading volume was a total of 791.00K shares. On April 23, 2024, KPTI opened at $1.12, traded as high as $1.17 and as low as $1.08, and closed at $1.09. Trading volume was a total of 1.59M shares. On April 24, 2024, KPTI opened at $1.10, traded as high as $1.15 and as low as $1.05, and closed at $1.09. Trading volume was a total of 1.20M shares.
KPTI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Karyopharm Therapeutics shares, starting with a $10,000 purchase of KPTI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$25.13 |
|
End price/share: |
$1.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.66% |
|
Average Annual Total Return: |
-26.94% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$433.68 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $1.28 | 04/19/2024 | $1.17 | 04/22/2024 | $1.13 | 04/23/2024 | $1.09 | 04/24/2024 | $1.09 |
|
|